Physician profile
James Savage
NPI 1851395446
$24,712.85
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,478 · 2020: $442 · 2021: $12K · 2022: $1,963 · 2023: $560 · 2024: $681.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,241.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $11,421.94 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $8,562.09 | 2019-2021 | |
| Alcon Vision LLC | $1,675.94 | 2019-2024 | Clareon, Simbrinza, Rocklatan |
| Allergan, INC. | $1,098.51 | 2019-2022 | |
| Abbvie INC. | $869.46 | 2022-2024 | Vuity, Lumigan, Alphagan P |
| Biotissue Holdings INC. | $234.96 | 2022-2024 | |
| Mallinckrodt Hospital Products INC. | $158.93 | 2022-2024 | Acthar |
| Bausch & Lomb Americas INC. | $154.24 | 2022-2024 | Vyzulta |
| Seagen INC. | $110.38 | 2022 | |
| Iridex Corporation | $100.83 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $89.38 | 2021 | |
| Novartis Pharmaceuticals Corporation | $67.45 | 2019-2021 | |
| Eyepoint US, INC. | $43.76 | 2022 | |
| Sun Pharmaceutical Industries INC. | $25.01 | 2019 | |
| Apellis Pharmaceuticals, INC. | $19.59 | 2024 | Syfovre |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $19.52 | 2019 | |
| Biogen, INC. | $15.57 | 2022 | |
| Kala Pharmaceuticals, INC. | $15.32 | 2019 | |
| Thea Pharma INC. | $15.25 | 2024 | Iyuzeh |
| Horizon Therapeutics Plc | $14.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Savage listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.